RIF1
Basic information
Region (hg38): 2:151409883-151508013
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RIF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 134 | 14 | 148 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 134 | 18 | 2 |
Variants in RIF1
This is a list of pathogenic ClinVar variants found in the RIF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-151410455-C-A | not specified | Uncertain significance (May 23, 2024) | ||
2-151410491-A-G | not specified | Uncertain significance (Jun 07, 2023) | ||
2-151411277-A-G | not specified | Uncertain significance (Jan 24, 2023) | ||
2-151411328-A-G | not specified | Uncertain significance (Jan 08, 2024) | ||
2-151414829-A-G | not specified | Uncertain significance (Nov 18, 2022) | ||
2-151414845-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
2-151416616-C-A | not specified | Uncertain significance (Oct 25, 2023) | ||
2-151416897-G-A | not specified | Likely benign (May 04, 2023) | ||
2-151420284-C-A | not specified | Uncertain significance (Jan 18, 2022) | ||
2-151420291-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
2-151420347-A-G | not specified | Uncertain significance (Nov 21, 2023) | ||
2-151428861-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
2-151428862-A-G | not specified | Uncertain significance (Mar 24, 2023) | ||
2-151428883-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
2-151428898-A-G | not specified | Uncertain significance (Mar 29, 2024) | ||
2-151435488-C-G | not specified | Uncertain significance (Dec 28, 2023) | ||
2-151435488-C-T | not specified | Uncertain significance (May 27, 2022) | ||
2-151436830-C-A | not specified | Uncertain significance (Nov 04, 2023) | ||
2-151436851-C-T | not specified | Uncertain significance (Apr 27, 2024) | ||
2-151436887-G-T | not specified | Uncertain significance (Sep 01, 2021) | ||
2-151436970-T-G | not specified | Uncertain significance (Feb 15, 2023) | ||
2-151437250-A-G | not specified | Uncertain significance (Aug 02, 2021) | ||
2-151437256-C-G | not specified | Uncertain significance (Dec 08, 2023) | ||
2-151437256-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
2-151437328-T-G | not specified | Uncertain significance (Feb 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RIF1 | protein_coding | protein_coding | ENST00000243326 | 35 | 98131 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 3.07e-13 | 125720 | 0 | 21 | 125741 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.414 | 1270 | 1.23e+3 | 1.03 | 0.0000606 | 16238 |
Missense in Polyphen | 242 | 333.04 | 0.72665 | 4396 | ||
Synonymous | -2.66 | 503 | 433 | 1.16 | 0.0000217 | 4659 |
Loss of Function | 8.96 | 6 | 105 | 0.0571 | 0.00000515 | 1497 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000186 | 0.000184 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000220 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000100 | 0.0000967 |
Middle Eastern | 0.000220 | 0.000217 |
South Asian | 0.0000441 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)- mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}.;
- Pathway
- Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);ATM Signaling Network in Development and Disease;DNA Repair;Nonhomologous End-Joining (NHEJ);DNA Double-Strand Break Repair
(Consensus)
Recessive Scores
- pRec
- 0.0948
Intolerance Scores
- loftool
- 0.489
- rvis_EVS
- -1.81
- rvis_percentile_EVS
- 2.18
Haploinsufficiency Scores
- pHI
- 0.636
- hipred
- N
- hipred_score
- 0.273
- ghis
- 0.619
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.929
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rif1
- Phenotype
- growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; embryo phenotype; immune system phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;telomere maintenance;double-strand break repair via nonhomologous end joining;chromatin silencing at telomere;cellular response to DNA damage stimulus;cell cycle;stem cell population maintenance;telomere maintenance in response to DNA damage;positive regulation of isotype switching;positive regulation of histone H3-K9 methylation;cellular response to leukemia inhibitory factor;negative regulation of double-strand break repair via homologous recombination;positive regulation of double-strand break repair via nonhomologous end joining
- Cellular component
- chromosome, telomeric region;nuclear chromatin;condensed chromosome;female pronucleus;male pronucleus;nucleus;nucleoplasm;cytoplasm;plasma membrane;nuclear body;nuclear membrane;site of double-strand break;spindle midzone
- Molecular function
- protein binding